003en NanoTrust Dossier
003en NanoTrust Dossier
003en NanoTrust Dossier
Myrtill Simkó*,
Michael Nentwich,
How Nanoparticles Enter the
André Gazsó, Ulrich Fiedeler Human Body and Their Effects There
Hair
Epidermis
Opening of
Sweat Gland
Capillaries
Sebaceous
Gland
Dermis
Muscle
Nerve
Sweat Gland
Subkutis
1
No. 003en • November 2010
2
No. 003en • November 2010
bust barrier consisting of an active epithe- remain in the brain and potentially accumu- sorbed particles. Some are taken up (inter-
lial layer that is protected by a viscous mu- late there18,19. Nanoparticles have also been nalized) by epithelial cells, as has been de-
cus layer (air-blood tissue barrier). In the gas demonstrated to penetrate into higher brain scribed for nano-scale titanium dioxide,
exchange area, the barrier between the alve- centers though this route (cortex, thalamus gold, polystyrene and zirconium)22,25. The
olar wall and the capillaries is very thin. The and cerebellum), with electroencephalograms underlying explanatory model states that the
air inside (in the lumen) of the alveoli is on- showing an altered pattern. released free radicals possibly trigger so-
ly a few nanometers away from the flowing called oxidative stress and irreparably dam-
blood. Animal experiments show that nano- age the cells (cytotoxicity). Other authors dis-
particles can cross this air-blood tissue bar- cuss the potential deposition of the nanopar-
rier. This introduces nanomaterials into the Effects on ticles directly onto the DNA, which can lead
body’s circulatory system14. Due to the large to a genotoxic effect20. Absorbed nanopar-
surface area of the alveoli and the intensive
the human body ticles can translocate from the lung into the
air-blood contact, the alveoli are more ex- blood10,14,27,28, whereby these results are be-
Animal experiments demonstrate that inflam-
posed to environmental influences than is the ing hotly debated. There is agreement that,
mations of the bronchi and alveoli can be
respiratory tract. The bronchi are coated with beyond the size of the particles, their surface
triggered by nanometer-sized carbon-, poly-
a mucociliary layer that removes particles de- texture and charge or coating can influence
styrene-, iron-, titanium dioxide- and iridi-
posited in the lungs (mucociliary clearance). the biological effectivity12,15.
um particles17,20. In individual cases, inflam-
This mucociliary clearance is sufficient to re-
matory reactions in occupationally exposed
move most of the nanoparticles deposited
persons have been described for nanoscale Conclusions
along the bronchi. The effectiveness of this
indium-zinc-oxides21 and zirconium particles
mechanism, however, decreases as particle Nanoparticles with a diameter of up to
from welding fumes22.
size decreases. This means that nanoparti- 100 nm, such as carbon or metallic ox-
cles enter the alveoli and are deposited on A range of data is available on the effects ide particles, are already present in the en-
the epithelium, after which a direct exchange of nanoparticles, whereby a close correla- vironment. They can induce biological ef-
with the alveolar epithelia can take place. tion exists between surface texture and bio- fects via cell membrane penetration and
So-called feeding cells (macrophages) take logical effects. In rats and mice, for exam- are more reactive than larger particles. The
over the task of removing foreign bodies be- ple, titanium dioxide (or nickel- and vana- use of nanoparticles, however, can im-
cause the alveoli lack a mucociliary clear- dium dioxide particles) measuring 20 nm ad- prove the efficiency of cosmetic products
ance mechanism. ministered directly into the lungs triggered for example, and makes it possible to cre-
stronger inflammatory reactions than 250 ate new coatings (e.g. scratch-proof
The minute size of the particles plays a key
nm particles. These and other results show paints). Moreover, they are considered as
role here as well. Animal experiments demon-
that toxicity is influenced more by the sur- candidates for new and promising med-
strate that the normal cleaning mecha-
face than by mass12. Moreover, beyond the ical applications and therapies. The in-
nisms can fail because insoluble nanopar-
size of the surface, its features (for example creasing use of nanoparticles, however,
ticles can be deposited for months to years
the presence of reactive groups on the sur- calls for further research in order to be able
in the bronchi and alveoli15. Higher depo-
face) determine the toxicity. In a special to conduct risk assessments. In particular,
sition rates have been reported in patients
mouse model, a recent pilot study shows that it is important to investigate the actual ex-
with chronic bronchitis and bronchial asth-
intraperitoneally administered (area of the posure of different groups such as con-
ma, whereby the reduced clearance and the
body covered by peritoneum), long (ca. sumers, occupationally exposed persons,
elevated breathing rates in these patients
20 μm), needle-shaped nanotubes can trig- and patients as well as both users and pro-
have been discussed as causes15,16.
ger chronic inflammation, while short and/or ducers of nanoparticles. In addition, the
How long the absorbed nanoparticles re- curved nanotubes induce no such effects. material uptake mechanisms need to be
main in the body (kinetics) remains unknown. Since their features (form, length and insol- investigated for a better understanding of
Some studies indicate that, after inhaling the ubility) resemble those of asbestos fibers, a the effects.
nanoparticles, these can enter other organs. comparable mechanism of action has been
Thus, after 7 days, inhaled nanoparticles were discussed23.
detected in the liver, spleen, brain, kidneys,
A key issue is a potential carcinogenic effect
heart and bone marrow12,17. A metaboliza-
of inhaled nanoparticles. The administration
tion of absorbed inorganic nanoparticles (for
of high doses of granular and biologically
example titanium dioxide) appears to be un-
stable nanodust (inert bulk material) in rats
likely, whereas organic nanomaterials (e.g.
was shown to be correlated with an elevat-
fullerenes) are more likely to be modified by
ed tumor frequency24. It remains unclear,
metabolic processes. Whether the particles
however, whether this involves a direct geno-
translocate into the lymphatic/blood circu-
toxic effect of the nanoparticles or whether
lation and become distributed and poten-
it reflects secondary reactions such as the re-
tially accumulate in the body, and whether
lease of free radicals, as is the case in chron-
they affect the cardiovascular system, is the
ic inflammations. The question of how small
subject of ongoing study.
amounts of nanoparticles behave in humans
Research is also being conducted on whether and whether they can induce cancer cannot
particles that reach the brain via breathing, be answered at this point. There is also un-
for example by way of the olfactory nerve, certainty about what happens with the ab-
3
No. 003en • November 2010
Notes and References 11 Kanapilly, G. M. and Diel, J. H., 1980, Ultra- 20 Elder, A. C., Gelein, R., Finkelstein, J. N., Cox,
fine 239PuO2 aerosol generation, character- C. and Oberdorster, G., 2000, Pulmonary in-
1 www.qualimedic.de/Haut.html (translated). ization and short-term inhalation study in the flammatory response to inhaled ultrafine parti-
2 Lademann, J., Weigmann, H., Rickmeyer, C., rat, Health Phys 39(3), 505-19. cles is modified by age, ozone exposure, and
Barthelmes, H., Schaefer, H., Mueller, G. and 12 Oberdorster, G., Oberdorster, E. and Ober- bacterial toxin, Inhal Toxicol 12 Suppl 4, 227-46.
Sterry, W., 1999, Penetration of titanium diox- dorster, J., 2005, Nanotoxicology: an emerg- 21 Homma, S., Miyamoto, A., Sakamoto, S., Kishi,
ide microparticles in a sunscreen formulation ing discipline evolving from studies of ultrafine K., Motoi, N. and Yoshimura, K., 2005, Pul-
into the horny layer and the follicular orifice, Skin particles, Environ Health Perspect 113(7), monary fibrosis in an individual occupational-
Pharmacol Appl Skin Physiol 12(5), 247-56. 823-39. ly exposed to inhaled indium-tin oxide, Eur
3 Lademann, J., Richter, H., Schaefer, U. F., 13 www.medizinfo.de/gastro/images/ Respir J 25(1), 200-4.
Blume-Peytavi, U., Teichmann, A., Otberg, N. duendarm.jpg (translated). 22 Kotter, J. M. and Zieger, G., 1992, Sarcoid
and Sterry, W., 2006, Hair follicles – a long- 14 granulomatosis after many years of exposure
Nemmar, A., Hoet, P. H., Vanquickenborne, B.,
term reservoir for drug delivery, Skin Pharma- to zirconium, “zirconium lung“, Pathologe 13(2),
Dinsdale, D., Thomeer, M., Hoylaerts, M. F.,
col Physiol 19(4), 232-6. 104-9.
Vanbilloen, H., Mortelmans, L. and Nemery,
4 Lademann, J., Schaefer, H., Otberg, N., Teich- 23
B., 2002, Passage of inhaled particles into the Poland, C.A., Duffin, R., Kinloch, I., Maynard,
mann, A., Blume-Peytavi, U. and Sterry, W., blood circulation in humans, Circulation 105(4), A., Wallace, W.A.H., Seaton, A., Stone, V.,
2004, Penetration of microparticles into human 411-4. Brown, S., William, M., Donaldson, K. 2008,
skin, Hautarzt 55 (12), 1117-9. 15 Carbon nanotubes introduced into the abdom-
Borm, P. J., Robbins, D., Haubold, S., Kuhl-
5 Ryman-Rasmussen, J. P., Riviere, J. E. and Mon- busch, T., Fissan, H., Donaldson, K., Schins, inal cavity of mice show asbestos-like patho-
teiro-Riviere, N. A., 2006, Penetration of in- R., Stone, V., Kreyling, W., Lademann, J., Krut- genicity in a pilot study, Nature Nanotechnol-
tact skin by quantum dots with diverse physic- mann, J., Warheit, D. and Oberdorster, E., ogy, Published online: 20 May 2008.
ochemical properties, Toxicol Sci 91(1), 159-65. 2006, The potential risks of nanomaterials: a 24 Roller, M. and Pott, F., 2006, Lung tumor risk
6 Rouse, J. G., Yang, J., Ryman-Rasmussen, J. review carried out for ECETOC, Part Fibre, Tox- estimates from rat studies with not specifical-
P., Barron, A. R. and Monteiro-Riviere, N. A., icol 3, 11. ly toxic granular dusts, Ann N Y Acad Sci 1076,
2007, Effects of mechanical flexion on the pen- 16 Frampton, M. W., Utell, M. J., Zareba, W., 266-80.
etration of fullerene amino acid-derivatized Oberdorster, G., Cox, C., Huang, L. S., Mor- 25 Geiser, M., Rothen-Rutishauser, B., Kapp, N.,
peptide nanoparticles through skin, Nano Lett row, P. E., Lee, F. E., Chalupa, D., Frasier, L. Schurch, S., Kreyling, W., Schulz, H., Semm-
7(1), 155-60. M., Speers, D. M. and Stewart, J., 2004, Ef- ler, M., Im Hof, V., Heyder, J. and Gehr, P.,
7 www.vitanet.de/media/img/106026727254 fects of exposure to ultrafine carbon particles 2005, Ultrafine particles cross cellular mem-
267493/lungenkrebs_lungenaufbau.gif in healthy subjects and subjects with asthma, branes by nonphagocytic mechanisms in lungs
(translated). Res Rep Health Eff Inst (126), 1-47; discussion and in cultured cells, Environ Health Perspect
8 49-63. 113(11), 1555-60.
Lomer, M. C., Thompson, R. P. and Powell, J.
17 Semmler, M., Seitz, J., Erbe, F., Mayer, P., Hey- 26 Stone, V., Johnston, H. and Clift, M. J., 2007,
J., 2002, Fine and ultrafine particles of the di-
et: influence on the mucosal immune response der, J., Oberdorster, G. and Kreyling, W. G., Air pollution, ultrafine and nanoparticle toxi-
and association with Crohn’s disease, Proc Nu- 2004, Long-term clearance kinetics of inhaled cology: cellular and molecular interactions,
tr Soc 61(1), 123-30. ultrafine insoluble iridium particles from the rat IEEE Trans Nanobioscience 6(4), 331-40.
9 lung, including transient translocation into sec- 27 Oberdorster, G., Sharp, Z., Atudorei, V., Elder,
Volkheimer, G., 1974, Passage of particles
ondary organs, Inhal Toxicol 16(6-7), 453-9. A., Gelein, R., Lunts, A., Kreyling, W. and Cox,
through the wall of the gastrointestinal tract,
18 Elder, A. and Oberdorster, G., 2006, Translo- C., 2002, Extrapulmonary translocation of ul-
Environ Health Perspect 9, 215-25.
10 cation and effects of ultrafine particles outside trafine carbon particles following whole-body
Kreyling, W. G., Semmler, M., Erbe, F., May-
of the lung, Clin Occup Environ Med 5(4), 785- inhalation exposure of rats, J Toxicol Environ
er, P., Takenaka, S., Schulz, H., Oberdorster,
96. Health A 65(20), 1531-43.
G. and Ziesenis, A., 2002, Translocation of ul-
19 Elder, A., Gelein, R., Silva, V., Feikert, T., Opan- 28 Nemmar, A., Vanbilloen, H., Hoylaerts, M. F.,
trafine insoluble iridium particles from lung ep-
ithelium to extrapulmonary organs is size de- ashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Hoet, P. H., Verbruggen, A. and Nemery, B.,
pendent but very low, J Toxicol Environ Health Y., Finkelstein, J. and Oberdorster, G., 2006, 2001, Passage of intratracheally instilled ul-
A 65(20), 1513-30. Translocation of inhaled ultrafine manganese trafine particles from the lung into the systemic
oxide particles to the central nervous system, circulation in hamster, Am J Respir Crit Care
Environ Health Perspect 114(8), 1172-8. Med 164(9), 1665-8.
MASTHEAD:
Owner: Austrian Academy of Sciences; legal person under public law
(BGBl 569/1921; BGBl I 130/2003); Dr. Ignaz Seipel-Platz 2, A-1010 Vienna
Editor: Institute of Technology Assessment (ITA); Strohgasse 45/5, A-1030 Vienna;
www.oeaw.ac.at/ita
Mode of publication: The NanoTrust Dossiers are published irregularly and contain the research
results of the Institute of Technology Assessment in the framework of its research project NanoTrust.
The Dossiers are made available to the public exclusively via the Internet portal “epub.oeaw” :
epub.oeaw.ac.at/ita/nanotrust-dossiers
NanoTrust-Dossier No. 003en, November 2010: epub.oeaw.ac.at/ita/nanotrust-dossiers/dossier003en.pdf
ISSN: 1998-7293
This Dossier is published under the Creative Commons
(Attribution-NonCommercial-NoDerivs 2.0 Austria)
licence: creativecommons.org/licenses/by-nc-nd/2.0/at/deed.en